Vanda Pharmaceuticals Inc (VNDA)
Depreciation & Amortization
$15.15M
TTM · Period ending: · USD
VNDA Depreciation & Amortization
Latest reported$15.15Mperiod ending
Latest reported$15.15Mperiod ending
VNDA TTM Depreciation & Amortization ($423.83K → $15.15M)
TTM Depreciation & Amortization
High-resolution chart · PNG
VNDA depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 15,148,000 | |
| 13,460,999 | |
| 11,916,999 | |
| 8,026,999 | |
| 7,940,999 | |
| 7,891,000 | |
| 8,132,000 | |
| 7,317,000 | |
| 5,930,000 | |
| 4,564,000 | |
| 3,010,000 | |
| 2,515,000 | |
| 2,613,000 | |
| 2,701,000 | |
| 2,733,000 | |
| 2,776,000 | |
| 2,806,000 | |
| 2,828,000 | |
| 2,841,000 | |
| 2,848,000 | |
| 2,858,000 | |
| 2,858,000 | |
| 2,864,000 | |
| 2,886,000 | |
| 2,894,000 | |
| 2,901,000 | |
| 2,892,000 | |
| 2,909,000 | |
| 2,931,000 | |
| 2,967,000 | |
| 2,956,000 | |
| 2,975,000 | |
| 3,001,000 | |
| 2,981,000 | |
| 2,984,000 | |
| 4,599,000 | |
| 6,987,000 | |
| 9,410,000 | |
| 11,868,000 | |
| 12,587,000 | |
| 12,525,000 | |
| 12,432,000 | |
| 13,554,000 | |
| 11,119,000 | |
| 8,687,000 | |
| 6,378,000 | |
| 2,784,000 | |
| 2,602,000 | |
| 2,420,000 | |
| 2,141,000 | |
| 1,927,000 | |
| 1,921,000 | |
| 1,916,000 | |
| 1,904,000 | |
| 2,128,000 | |
| 2,208,000 | |
| 2,250,000 | |
| 2,218,000 | |
| 1,964,000 | |
| 1,857,008 | |
| 1,789,987 | |
| 1,814,301 | |
| 1,831,000 | |
| 1,847,808 | |
| 1,875,736 | |
| 1,764,648 | |
| 1,424,744 | |
| 1,080,592 | |
| 740,119 | |
| 530,971 | |
| 530,805 | |
| 527,921 | |
| 537,633 | |
| 545,544 | |
| 571,586 | |
| 606,981 | |
| 605,015 | |
| 603,808 | |
| 575,372 | |
| 522,590 | |
| 477,617 | |
| 430,930 | |
| 423,828 |